Physicians' Academy for Cardiovascular Education
Report; CV Risk Management 2016 - Applying the latest insights to clinical care

Report; CV Risk Management 2016 - Applying the latest insights to clinical care

Yogyakarta, Java - Indonesia October 22, 2016

Oct. 24, 2016

This Master Class program is a global initiative of the PACE-CME foundation with a particular focus on issues and opportunities in cardiovascular risk and lipid management in high risk patients

Agenda & Faculty

Cardiovascular Disease: The ongoing journey to manage the risk - University College London, London, United Kingdom

Managing CV Risk in Indonesia: How well are we doing and where can we improve? - Anwar Santoso, MD, University of Indonesia, Jakarta, Indonesia

Managing lipids: Integrating novel insights with gold standard therapies - Philip Barter, MD, University of Sydney, Sydney, Australia

Blood pressure: How do recent trial outcomes impact our hypertension management? - Neil Poulter, MD, Imperial College London, United Kingdom

Guidance in CV Risk management: How to deal with international guidelines? - Philip Barter, MD, Sydney, Australia

CV Risk guidelines for Indonesia: What and how to follow? - Renan Sukmawan, MD, Harapan Kita National Cardiovascular Centre, Jakarta-Indonesia

T2DM & CVD: An update on current and new strategies improving outcomes - Neil Poulter, MD, Imperial College London, United Kingdom

Educational information

The overall educational objectives of the Cardiovascular Master Class were to:

CME accreditation

This Master Class was endorsed and accredited by the Indonesian Cardiology Association

Funding

The CV Risk Master Class was funded by an unrestricted educaional grant provided by Pfizer

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.